| Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial RL Coleman, AM Oza, D Lorusso, C Aghajanian, A Oaknin, A Dean, ... The Lancet 390 (10106), 1949-1961, 2017 | 1590 | 2017 |
| Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome KM Schmeler, HT Lynch, L Chen, MF Munsell, PT Soliman, MB Clark, ... New England Journal of Medicine 354 (3), 261-269, 2006 | 946 | 2006 |
| Risk factors for young premenopausal women with endometrial cancer PT Soliman, JC Oh, KM Schmeler, CC Sun, BM Slomovitz, ... Obstetrics & Gynecology 105 (3), 575-580, 2005 | 472 | 2005 |
| Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases BM Slomovitz, TW Burke, PJ Eifel, LM Ramondetta, EG Silva, A Jhingran, ... Gynecologic oncology 91 (3), 463-469, 2003 | 426 | 2003 |
| The PI3K/AKT/mTOR pathway as a therapeutic target in endometrial cancer BM Slomovitz, RL Coleman Clinical Cancer Research 18 (21), 5856-5864, 2012 | 425 | 2012 |
| Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases PT Soliman, BM Slomovitz, RR Broaddus, CC Sun, JC Oh, PJ Eifel, ... Gynecologic oncology 94 (2), 456-462, 2004 | 339 | 2004 |
| Association between adiponectin, insulin resistance, and endometrial cancer PT Soliman, D Wu, G Tortolero‐Luna, KM Schmeler, BM Slomovitz, ... Cancer 106 (11), 2376-2381, 2006 | 333 | 2006 |
| Comparison of total laparoscopic and abdominal radical hysterectomy for patients with early-stage cervical cancer RW Holloway, NJ Finkler, DP Pikaart, GE Bigsby IV, SA DeNardis, ... Obstetrics & Gynecology 110 (5), 1174, 2007 | 322 | 2007 |
| A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma BM Slomovitz, KH Lu, T Johnston, RL Coleman, M Munsell, RR Broaddus, ... Cancer 116 (23), 5415-5419, 2010 | 297 | 2010 |
| Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma BM Slomovitz, Y Jiang, MS Yates, PT Soliman, T Johnston, ... Journal of Clinical Oncology 33 (8), 930, 2015 | 283 | 2015 |
| Her-2/neu Overexpression and Amplification in Uterine Papillary Serous Carcinoma BM Slomovitz, RR Broaddus, TW Burke, N Sneige, PT Soliman, W Wu, ... Journal of Clinical Oncology 22 (15), 3126-3132, 2004 | 258 | 2004 |
| The utility of venous lactate to triage injured patients in the trauma center RF Lavery, DH Livingston, BJ Tortella, JT Sambol, BM Slomovitz, ... Journal of the American College of Surgeons 190 (6), 656-664, 2000 | 248 | 2000 |
| Total laparoscopic radical hysterectomy and lymphadenectomy: the MD Anderson Cancer Center experience PT Ramirez, BM Slomovitz, PT Soliman, RL Coleman, C Levenback Gynecologic oncology 102 (2), 252-255, 2006 | 214 | 2006 |
| Dostarlimab for primary advanced or recurrent endometrial cancer MR Mirza, DM Chase, BM Slomovitz, R dePont Christensen, Z Novák, ... New England Journal of Medicine 388 (23), 2145-2158, 2023 | 203 | 2023 |
| Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer M Frumovitz, BM Slomovitz, DK Singh, RR Broaddus, J Abrams, CC Sun, ... Journal of the American College of Surgeons 199 (3), 388-393, 2004 | 172 | 2004 |
| Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1–2 trial JS De Bono, N Concin, DS Hong, FC Thistlethwaite, JP Machiels, ... The lancet oncology 20 (3), 383-393, 2019 | 155 | 2019 |
| Are women ready for the HPV vaccine? BM Slomovitz, CC Sun, M Frumovitz, PT Soliman, KM Schmeler, ... Gynecologic oncology 103 (1), 151-154, 2006 | 142 | 2006 |
| A phase II, randomized, placebo-controlled study of vismodegib as maintenance therapy in patients with ovarian cancer in second or third complete remission SB Kaye, L Fehrenbacher, R Holloway, A Amit, B Karlan, B Slomovitz, ... Clinical Cancer Research 18 (23), 6509-6518, 2012 | 134 | 2012 |
| Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome PT Soliman, RR Broaddus, KM Schmeler, MS Daniels, D Gonzalez, ... J Clin Oncol 23 (36), 9344-9350, 2005 | 126 | 2005 |
| Safety and efficacy of adoptive cell transfer using autologous tumor infiltrating lymphocytes (LN-145) for treatment of recurrent, metastatic, or persistent cervical carcinoma. AA Jazaeri, E Zsiros, RN Amaria, AS Artz, RP Edwards, RM Wenham, ... Journal of Clinical Oncology 37 (15_suppl), 2538-2538, 2019 | 113 | 2019 |
Russell BroaddusUniversity of North Carolina School of MedicineПідтверджена електронна адреса в med.unc.edu
